Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome

被引:60
|
作者
Catteau-Jonard, Sophie
Pigny, Pascal
Reyss, Anne-Celine
Decanter, Christine
Poncelet, Edouard
Dewailly, Didier
机构
[1] Ctr Hosp Reg Univ Lille, Hop Jeanne Flandre, Dept Endocrine Gynaecol & Reprod Med, F-59037 Lille, France
[2] Ctr Hosp Reg Univ Lille, Hop Jeanne Flandre, Dept Radiol, F-59037 Lille, France
[3] Ctr Hosp Reg Univ Lille, Lab Endocrinol, F-59037 Lille, France
来源
关键词
D O I
10.1210/jc.2007-0868
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: We previously hypothesized that the excess of anti-mullerian hormone (AMH) at the level of selectable follicles could be involved in the follicular arrest of polycystic ovary syndrome ( PCOS), mainly through inhibition of FSH effect on aromatase expression. Objective: In this study, we investigated whether a decrease in the serum AMH level was concomitant to the appearance of a dominant follicle induced by administration of mild amounts of exogenous FSH in women with PCOS. Design: A total of 30 women with PCOS in whom anovulation was resistant to clomiphene citrate received recombinant FSH using the low-dose step-up protocol during only one cycle. Serum levels of estradiol, AMH, LH, FSH, inhibin B, and ultrasound parameters were assessed twice a week until 3 d after the appearance of one or more dominant follicle(s). Results: The day of dominance ( d 0) was defined by the appearance of at least one follicle more than 10 mm growing 2 mm/d. From d - 14 before dominance to d - 3, the mean serum AMH level and the 2- to 5-mm follicle number at ultrasound declined steadily, although not significantly by ANOVA. Mean AMH relative values (100% being the value at d 0) declined significantly ( P = 0.04), from 125 +/- 32% at d - 14 to 105 +/- 15% at d - 4. Within the same time lag, the mean FSH relative values increased from 91 +/- 17% to 107 +/- 19% ( P = 0.013). In the 87 samples obtained from d - 14 to -4, absolute values of AMH were positively and negatively associated with those of LH and FSH, respectively, in an independent manner ( P = 0.009 and P = 0.03, respectively). In the 55 samples collected at d 0 and +3, they were negatively correlated to those of estradiol ( r = -0.272; P < 0.05). Conclusions: These data suggest that in anovulatory women with PCOS, gently increasing the serum FSH level reduces the AMH excess, thus relieving the inhibition from the latter on aromatase expression by selectable follicles and allowing the emergence of a dominant follicle.
引用
收藏
页码:4138 / 4143
页数:6
相关论文
共 50 条
  • [1] Anti-Mullerian hormone and polycystic ovary syndrome
    Lebkowska, Agnieszka
    Kowalska, Irina
    [J]. ENDOKRYNOLOGIA POLSKA, 2017, 68 (01) : 74 - 78
  • [2] Anti-Mullerian hormone and polycystic ovary syndrome
    Catteau-Jonard, S.
    Dewailly, D.
    [J]. GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2011, 39 (09): : 514 - 517
  • [3] Serum anti-Mullerian hormone and polycystic ovary syndrome: a matter of methods?
    Parco, S.
    Novelli, C.
    Princi, T.
    [J]. MINERVA PEDIATRICA, 2014, 66 (04) : 335 - 336
  • [4] Role of anti-Mullerian hormone in polycystic ovary syndrome
    Bhattacharya, Koushik
    Saha, Ishita
    Sen, Debanjana
    Bose, Chaitali
    Chaudhuri, Gargi Ray
    Dutta, Sulagna
    Sengupta, Pallav
    Bhattacharya, Soumita
    Barman, Sharit Shekhar
    Syamal, Alak Kumar
    [J]. MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2022, 27 (01)
  • [5] Role of anti-Mullerian hormone in polycystic ovary syndrome
    Koushik Bhattacharya
    Ishita Saha
    Debanjana Sen
    Chaitali Bose
    Gargi Ray Chaudhuri
    Sulagna Dutta
    Pallav Sengupta
    Soumita Bhattacharya
    Sharit Shekhar Barman
    Alak Kumar Syamal
    [J]. Middle East Fertility Society Journal, 27
  • [6] Anti-Mullerian hormone in patients with polycystic ovary syndrome
    Chebotnikova, T.
    Ilyin, A.
    Melnichenko, G.
    Chernukha, G.
    [J]. GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2012, 34 (01): : 140 - 140
  • [7] Anti-Mullerian hormone dynamics during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome
    Dabkowska-Huc, Anna
    Lemm, Magdalena
    Sikora, Jerzy
    Witek, Andrzej
    Skalba, Piotr
    [J]. ENDOKRYNOLOGIA POLSKA, 2013, 64 (03) : 203 - 207
  • [8] The relationship between serum anti-Mullerian hormone levels and the follicular arrest for women with polycystic ovary syndrome
    Li, Jian
    Li, Rong
    Yu, Hua
    Zhao, Shuyun
    Yu, Yang
    Qiao, Jie
    [J]. SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2015, 61 (02) : 103 - 109
  • [9] Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
    Angela Falbo
    Morena Rocca
    Tiziana Russo
    Antonietta D'Ettore
    Achille Tolino
    Fulvio Zullo
    Francesco Orio
    Stefano Palomba
    [J]. Journal of Ovarian Research, 3
  • [10] Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
    Falbo, Angela
    Rocca, Morena
    Russo, Tiziana
    D'Ettore, Antonietta
    Tolino, Achille
    Zullo, Fulvio
    Orio, Francesco
    Palomba, Stefano
    [J]. JOURNAL OF OVARIAN RESEARCH, 2010, 3